A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection
SARS-CoV-2 감염에 대한 항바이러스제의 효능을 평가하기 위한 SCID 마우스 모델
Article
[키워드] ACE2 receptor
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Antiviral
antiviral drug
antiviral drugs
antiviral efficacy
antivirals
B.1.351
B.1.351 variant
BALB/c
Beta
Beta variant
binding
C57BL/6
CAGE
coronavirus
Culture
drug
hamsters
Infection
infectious virus titer
infectious virus titers
Infective dose
inhibitors
intrinsic
lack
log
lung
Lung pathology
Lungs
male
mice
Model
moderate
molnupiravir
mouse
mouse model
Mouse models
Nirmatrelvir
offer
Postinfection
reagent
receptor
reduced
replicate
Replication
reported
SARS-CoV-2
SARS-CoV-2 mouse model
SARS-CoV-2 strain
SARS-CoV2
SCID
significantly
TCID
These data
tissue
tissue culture
twice a day
Validity
variant
variants
variants of concern
Viral load
virus
virus strain
wild-type
[DOI] 10.1128/jvi.00758-22 PMC 바로가기 [Article Type] Article
[DOI] 10.1128/jvi.00758-22 PMC 바로가기 [Article Type] Article